Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4global Regulatory News (4GBL)

  • There is currently no data for 4GBL

Director Share Purchase / PDMR Dealing

24 May 2022 16:45

RNS Number : 6584M
4GLOBAL PLC
24 May 2022
 

24 May 2022

4Global plc

("4Global" or the "Company")

Director Share Purchase / PDMR Dealing

The Company has today been notified that Maeda Cinco S.L., a company in which the Company's Chief Executive Eloy Mazon has an interest, purchased on 23 May 2022 a total of 3,000 Ordinary Shares of 1p each in the Company at an average price of 77 pence per share.

Following these transactions, Eloy Mazon has a beneficial interest in a total of 13,370,017 Ordinary Shares, (13,304,017 in his own name and 66,000 in Maeda Cinco S.L. ) representing, in aggregate, 50.75 per cent. of the Company's issued ordinary share capital.

The notification below, made in accordance with the Market Abuse Regulation, provides further details in relation to the purchase of Ordinary Shares.

NOTIFICATIONS AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Eloy Mazon

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR (Executive Director)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

4Global Plc

b)

 

LEI

 

 

89450099YF5FU8P84Z25

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

Identification code

GB00BLH36N37

 

b)

 

Nature of the transaction

 

 

Purchase of ordinary shares by Maeda Cinco S.L., a company in which Mr Mazon has a beneficial interest.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

77p

 

 

3,000

 

 

 

d)

 

Aggregated information

- Aggregated volume

As above

- Total Price

e)

 

Date(s) of the transaction

 

 

23 May 2022

f)

 

Place of the transaction

 

 

AIMX

 

 

 

**ENDS**

 

 

For further information please contact:

4GLOBAL

c/o IFC Advisory

Eloy Mazon (CEO)

 

 

Spark Advisory Partners - Nominated Adviser

0203 368 3554

Neil Baldwin

 

 

Oberon Capital - Broker

0203 179 5300

Michael Seabrook, Adam Pollock, Chris Crawford

 

 

IFC Advisory

 

0203 934 6630

Graham Herring / Zach Cohen

 

07793 839 024

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASSLALLAEFA
12
Date   Source Headline
7th Jul 20257:00 amRNSCancellation - 4GLOBAL PLC
2nd Jul 20256:00 pmRNS4GLOBAL
25th Jun 202510:36 amRNSResult of General Meeting
9th Jun 20259:03 amRNSHolding(s) in Company
4th Jun 20257:00 amRNSProposed Cancellation
23rd May 20253:42 pmRNSNotification of Major Holdings
10th Apr 20257:00 amRNSUK Sport Contract Win
4th Apr 20253:13 pmRNSRelated Party Transaction
3rd Apr 20257:00 amRNSSport England Contract Renewal and Expansion
28th Mar 20257:00 amRNSBoard Change
20th Mar 20257:00 amRNSNotification of Major Holdings
19th Mar 20257:00 amRNSTrading Update
10th Mar 20257:00 amRNSAppointment of Non-Executive Director
10th Mar 20257:00 amRNSLaunch of Insight.OS
21st Jan 20257:00 amRNSNew Market Entry
12th Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSNotice of Results & Investor Presentation
26th Nov 20244:41 pmRNSHolding(s) in Company
24th Oct 20243:51 pmRNSIssue of Share Options
23rd Oct 20247:00 amRNSNew US Strategic Partnerships
16th Oct 20247:00 amRNSSignificant contract extension and expansion
8th Oct 20241:11 pmRNSNotification of Major Holdings
30th Sep 202412:57 pmRNSResult of AGM
30th Sep 20247:00 amRNSAGM Statement
23rd Sep 20247:00 amRNSU.S. Soccer Contract Expansion
11th Sep 20247:00 amRNSManagement Transition
3rd Sep 20247:00 amRNSPublication of Annual Report
6th Aug 202412:46 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSUnaudited Preliminary Results
3rd Jul 20247:00 amRNSNotice of Results & Investor Presentation
24th Jun 202410:43 amRNSHolding(s) in Company
30th May 202411:07 amRNSHolding(s) in Company
15th May 20247:00 amRNSTrading Update
8th May 20242:38 pmRNSNotification of Major Holdings
23rd Apr 20248:00 amRNSIssue of share options
22nd Apr 20247:00 amRNSCorrection: Holding(s) in Company
22nd Apr 20247:00 amRNSDirectorate Changes
17th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20244:17 pmRNSIssue of share options
11th Mar 20247:00 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSDirectorate Change
22nd Jan 20245:14 pmRNSBoard Change
16th Jan 20247:00 amRNSContract Wins
7th Dec 20237:00 amRNSInterim Results
15th Nov 20237:00 amRNSContract Extension
17th Oct 20237:00 amRNSContract Wins
27th Sep 202312:11 pmRNSResult of AGM
27th Sep 20237:00 amRNSTrading Update
13th Sep 20237:00 amRNSArtificial Intelligence and Machine Learning Trial
30th Aug 20237:00 amRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.